An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

IO Biotech said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's ...

IO Biotech said on Monday its experimental cancer vaccine, in combination with Merck's Keytruda, showed improvement in a late ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...

New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.

The vaccine doesn't prevent cancer from happening in the first place, but an early-phase trial found it could reduce the odds ...

The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.

A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...